Author

Marie Michelas

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Maha AyyoubiD· 2 shared Adrian Valente· 1 shared Alejandra MartíneziD· 1 shared Amy J. HeidersbachiD· 1 shared Anna SalvioniiD· 1 shared Audrey PageiD· 1 shared Bastien CabarrouiD· 1 shared Carlos Gomez‐RocaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Maha AyyoubORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systemic neoantigen-specific T cells reveal central determinants of PD-(L)1 blockade efficacy

Célia Ramade, Noémie Thébault, Clara‐Maria Scarlata, Daniel Oreper, Françoise Lauzéral-Vizcaïno, Suchit Jhunjhunwala, Bastien Cabarrou, Milena Hornburg, Caroline Fournier, Anna Salvioni, Marie Michelas, Victor Sarradin, Giulia Costanza Leonardi, Virginie Féliu, Myriam Maixent, , Maha Ayyoub

The paper identifies coordinated neoantigen-specific CD8 T cell responses as key predictors of PD-(L)1 therapy efficacy in non-small cell lung cancer patients.

bioRxiv · Mar 12, 2026 · PreprintCancer Biology

HERV-derived epitopes represent new targets for T-cell based immunotherapies in ovarian cancer

Paola Bonaventura, Audrey Page, Olivier Tabone, Yann Estornes, Virginie Mutez, Marie Delles, Sarah Moran, Clarisse Dubois, Thibault Richard, Marjorie Lacourrège, Marie Michelas, Dina M. Tawfik, Ema Etchegaray, Adrian Valente, Rasha E. Boulos, , Stéphane Depil

This study identifies HERV-derived epitopes as potential targets for T-cell immunotherapies in ovarian cancer, showing their expression in tumors and immunogenicity in patients.

Journal for ImmunoTherapy of Cancer · Aug 1, 2025Peer-reviewedImmunology